1. Home
  2. NNBR vs NKTX Comparison

NNBR vs NKTX Comparison

Compare NNBR & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNBR
  • NKTX
  • Stock Information
  • Founded
  • NNBR 1980
  • NKTX 2015
  • Country
  • NNBR United States
  • NKTX United States
  • Employees
  • NNBR N/A
  • NKTX N/A
  • Industry
  • NNBR Industrial Machinery/Components
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNBR Industrials
  • NKTX Health Care
  • Exchange
  • NNBR Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • NNBR 111.0M
  • NKTX 123.5M
  • IPO Year
  • NNBR 1994
  • NKTX 2020
  • Fundamental
  • Price
  • NNBR $1.97
  • NKTX $1.77
  • Analyst Decision
  • NNBR
  • NKTX Strong Buy
  • Analyst Count
  • NNBR 0
  • NKTX 6
  • Target Price
  • NNBR N/A
  • NKTX $14.40
  • AVG Volume (30 Days)
  • NNBR 215.6K
  • NKTX 429.7K
  • Earning Date
  • NNBR 08-06-2025
  • NKTX 08-12-2025
  • Dividend Yield
  • NNBR N/A
  • NKTX N/A
  • EPS Growth
  • NNBR N/A
  • NKTX N/A
  • EPS
  • NNBR N/A
  • NKTX N/A
  • Revenue
  • NNBR $448,780,000.00
  • NKTX N/A
  • Revenue This Year
  • NNBR N/A
  • NKTX N/A
  • Revenue Next Year
  • NNBR $4.96
  • NKTX N/A
  • P/E Ratio
  • NNBR N/A
  • NKTX N/A
  • Revenue Growth
  • NNBR N/A
  • NKTX N/A
  • 52 Week Low
  • NNBR $1.58
  • NKTX $1.31
  • 52 Week High
  • NNBR $4.67
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • NNBR 47.29
  • NKTX 46.34
  • Support Level
  • NNBR $1.82
  • NKTX $1.76
  • Resistance Level
  • NNBR $2.10
  • NKTX $2.08
  • Average True Range (ATR)
  • NNBR 0.15
  • NKTX 0.11
  • MACD
  • NNBR -0.02
  • NKTX -0.00
  • Stochastic Oscillator
  • NNBR 26.79
  • NKTX 25.00

About NNBR NN Inc.

NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: